Joan Carles DOMINGO PEDRO,Jose Antonio VILLEGAS GARCIA
申请号：
US15018057
公开号：
US20160151320A1
申请日:
2016.02.08
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to the use of an acid enriched in docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) or DHA-derived EPA for manufacturing a drug for the treatment of processes that involve associated oxidative damage. In particular, it is for the treatment of processes associated with neurodegenerative, ocular, ischaemic and inflammatory pathology, atherosclerosis, with oxidative damage to DNA and with physical exercise.
